ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676536 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676536; 2) Community: the network communities that were significantly associated with the response to NSC 676536; 3) Molecule: the relationships between components within communities and NSC 676536; 4) MDR: the compounds that were significantly associated with the NSC 676536.

NSC Compound Enrichment Correlation
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0135714101922724 0.40135617
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0135714101922724 0.39149367
NSC 750873 2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.0135714101922724 0.29016324
NSC 762346 Null 0.0135714101922724 0.36860818
NSC 92207 Null 0.0135714101922724 0.14458235
NSC 269760 B8 0.0139796580235792 0.38916543
NSC 303861 L-Cysteine analog 0.0139796580235792 0.53759338
NSC 321240 Null 0.0139796580235792 0.23438373
NSC 339137 PHYSALOLACTONE 0.0139796580235792 0.4970268
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0139796580235792 0.35920982
Total:106  Current:46    [First] [Prev] [Next] [Last]